Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared on LinkedIn:
”Thalassemia is a rare blood disorder that still affects about 7,000 patients in Italy, many of whom depend on lifelong transfusions.
Research has changed the course of this disease in recent decades, but much remains to be done to prevent complications and move closer to a cure.
At the Franco and Piera Cutino Foundation we work every day on research, prevention and innovative therapies, from early prenatal diagnosis to gene therapy and international collaboration on rare hematologic diseases.
In this video I share the mission and the projects we are advancing, also supported by our Easter solidarity campaign ‘Giving makes you happy’.”
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America
-
Apr 22, 2026, 07:02Michael Wong: Predicting Blood Clots is a Patient Safety Issue